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AbstrAct
Introduction: Hyponatraemia is the most common electrolyte abnormality in hospitalized patients and is associated 
with poor prognosis and high mortality. There is a paucity of data on hyponatraemia in Ghana. We set out to 
describe the prevalence of this condition, its associations and the outcomes in terms of in-hospital mortality and 
length of hospital stay.
Methods: We conducted a retrospective study of all admissions from October 2017 to April 2018 on the medical 
ward at the Komfo Anokye Teaching Hospital (KATH). Demographic information, medical diagnoses as well as 
clinical and laboratory data were documented. Means (± standard deviation) were recorded for normally distributed 
data, whereas non-normally distributed data were recorded as medians [interquartile range (IQR)]. Chi-squared and 
Fisher’s exact tests were used to test categorical variables. ANOVA and Kruskal-Wallis tests were used for the 
analysis of hyponatraemia severity; a p value of < 0.05 was considered statistically significant. 
Results: Within the study period, 406 patients with hyponatraemia were identified in 1477 medical admissions, a 
prevalence of 27.6%. Their mean age was 51.5 ± 19.0 years. There were 217 males (53.5%). The mean serum sodium 
was 128.7 ± 6.5 mmol/L. Two hundred and forty (59%) had mild hyponatraemia, 106 (26%) had moderate 
hyponatraemia and 60 (15%) had severe hyponatraemia. The most common associated medical conditions were 
infections (26%), chronic liver disease (17%), hyperglycaemia (17%), chronic kidney disease (16%) and chronic heart 
failure (8%). In-hospital mortality was 31.8% and varied with the severity of the hyponatremia. The median length of 
hospital stay was 7 days (IQR 4–10 days) and did not vary with the severity of hyponatraemia. Mortality was 
associated with serum sodium concentration (p = 0.007) and lower levels of consciousness (Glasgow Coma Scale, 
GCS, ≤ 13) at presentation (p < 0.001).
Conclusions: Hyponatraemia is common in medical admissions in Ghana, and is mostly associated with infections, 
and chronic liver, kidney and heart diseases. It is associated with high in-hospital mortality, especially when 
hyponatraemia is more severe or accompanied by relatively low GCS scores.  
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INtrODUctION
Hyponatraemia, defined by a  serum sodium concentration 
of less than 135 mmol/L, is the most common electrolyte 
abnormality in hospitalized patients [1,2]. It is present in 
approximately 15% of hospital admissions [3], is asso-
ciated with increased morbidity and mortality, and is 
often poorly recognised and managed. Normally, serum 
sodium concentration is tightly controlled by mechanisms 
including antidiuretic hormone (ADH) and the thirst 
response. Abnormalities in serum sodium concentration 
indicate a disruption in the body’s control systems for 
water [2,4]. 
There are many causes that may contribute to hypo-
natraemia. They include medications, malignancies, infec-
tions, cardiac failure, liver failure and renal disease. These 
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conditions are mostly described as causing the syndrome 
of inappropriate anti-diuretic hormone (SIADH) secretion, 
where ADH is acting when the serum sodium concentration 
and/or serum osmolality is low. Non-osmotic states such 
as pain, anxiety and nausea can also cause ADH secretion 
and hyponatraemia [5]. Acute hyponatraemia has also 
been described in long-distance runners due to water 
overload [6]. The condition may present with symptoms 
ranging from headache, nausea, vomiting and fatigue to 
seizures and coma.
In hospitalized patients, a serum sodium concentration of 
less than 125 mmol/L has been associated with poor prog-
nosis. Mortality rates associated with hyponatraemia range 
from 0.9–29.6% of hospital admissions with the highest 
among patients in the intensive care units [7,8]. It is not 
certain whether hyponatraemia contributes to the higher 
mortality or is just a marker of the poor prognosis in 
chronic conditions [9].
In Ghana, there has been no study on the prevalence and 
outcomes of hyponatraemia in hospitalized patients. There 
have been case studies describing the condition in patients 
with hypothyroidism [10] and bronchial carcinoma [11].  In 
this study, we describe the prevalence of hyponatraemia in 
a tertiary institution in Ghana, and describe the causes and 
outcomes among patients in terms of in-hospital mortality 
and length of hospital stay. 
MEtHODs
We conducted a retrospective study of adult (>18 years) 
medical admissions at the Komfo Anokye Teaching Hospital 
(KATH) with serum sodium concentration less than 
135 mmol/L. The study period was from 1 October 2017 
to 30 April 2018. KATH is a 1200-bed hospital in the 
Ashanti region, which receives referrals from about half of 
Ghana’s 27 million population in the northern half of the 
country. The hospital has twelve clinical directorates 
including the Internal Medicine directorate with a bed 
capacity of 203.  
Two patients among the medical admissions were not 
considered for inclusion as they did not have serum sodium 
measurements. Demographic data including age and sex 
were recorded. Presenting symptoms such as nausea, 
vomiting, oedema, seizures and pain were recorded if 
documented in the clinical notes. Level of consciousness 
graded using the Glasgow Coma Scale (GCS) was also 
recorded. Low level of consciousness was defined as GCS 
of ≤ 13. Serum sodium concentration was categorised as 
mild when between 130–134 mmol/L, moderate between 
125–129 mmol/L and severe when less than 125 mmol/L. 
Critical hyponatraemia was defined as serum sodium 
concentration of less than 120 mmol/L. The medical 
diagnoses were also recorded and the most likely con-
tributory causes of the hyponatraemia were identif ied. 
Outcome variables documented were the length of hospital 
stay and in-hospital mortality.
Means and standard deviation were used to describe 
normally distributed variables and medians and interquartile 
range for variables not normally distributed. Figures and 
tables were used to describe data where appropriate. The 
chi-squared and Fisher’s exact tests were used for cate-
gorical variables. Student’s t test and the Wilcoxon sign 
rank test were used for continuous variables. ANOVA and 
Kruskal-Wallis tests were used to test for differences 
related to the severity of hyponatremia.  Multiple logistic 
regression was then used to identify predictors of mortality. 
A P value of < 0.05 was considered statistically significant. 
Ethical approval was granted before the start of the study 
from the Committee on Human Research, Publications and 
Ethics, School of Medical Sciences, Kwame Nkrumah 
University of Science and Technology.
rEsULts
The study identified 406 patients with hyponatraemia in 
1479 medical admissions within the study period, yielding a 
prevalence of 27.6%. The mean age was 51.5 ± 19.0 years. 
There were 217 males (53.5%). The mean serum sodium 
concentration was 128.7 ± 6.5 mmol/L (Table 1). 
The most common medical conditions associated with 
hyponatraemia were infections (105 patients, 26%), chronic 
liver disease (69, 17%), diabetes mellitus (68, 17%) and 
chronic kidney disease (66, 16%) (Figure 1).  When 
hyponatraemia was classified by volume status, 17% were 
hypovolaemic, 41% were euvolaemic and 43% were 
hypervolaemic. 
In-hospital mortality was 32%. Of the patients who died, 
mortality varied significantly with the diagnosis (p = 0.012), 
with the highest rate among patients with malignancies 
(46%), cranial pathologies (44%), chronic liver disease 
(41%), chronic kidney disease (38%) and infections (35%) 
(Figure 1). 
In-hospital mortality also varied with the severity of 
hyponatraemia. Mild hyponatraemia had an associated 
mortality rate of 21%, moderate hyponatraemia 45% and 
severe hyponatraemia 52% (p < 0.001). Mortality did not 
vary with volume status. 
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The median duration of hospital stay was 7 days (IQR 4–10 
days) and did not vary significantly with the severity of 
hyponatraemia.
Among patients with GCS ≤13, 67% died (p < 0.001). The 
mean serum sodium for those who died was lower, 126.0 
± 8.5 mmol/L versus 129.9 ± 4.8 mmol/L (p < 0.001). The 
in-hospital mortality of those with critical hyponatraemia 
was 70%. 
Multiple logistic regression revealed that serum sodium 
concentration (p = 0.007) and GCS ≤ 13 (p < 0.001) were 
predictors of mortality (Table 3).
DIscUssION
This is the first study of hyponatremia in Ghana describing 
the prevalence, causes and outcomes of the condition. 
We report a hyponatraemia prevalence of 27.6% in our 
hospitalized medical cases, similar to prevalences in other 
studies of 15–36% [3,12]. Hyponatraemia was seen mostly 
in patients with infections and chronic oedematous con-
ditions such as liver, heart and kidney disease, and had 
a high in-hospital mortality. Mortality was associated with 
the severity of hyponatraemia and decreased level of 
consciousness. 
There were more males with hyponatraemia, which 
contrasts with other reports in which females were at 
higher risk as a result of their lower body weight and total 
body water [13]. Higher proportions of males have also 
been reported in hospitalized patients, especially among 
those with chronic heart failure, chronic liver disease and 
malignancies [14]. Our higher proportion of males may be 
due to the frequency of chronic liver disease, alcoholism 
and CKD in our study.
Infections were the most common cause of hyponatremia 
in our cohort. Infections such as pneumonia have been 
reported as a cause of hyponatraemia in 28% of cases 
in another study [15]. Hyponatraemia in the setting of 
infections may be due to renal hypoperfusion, leading to 
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table 1.  Demographics and clinical data of patients with hyponatraemia.
Variable total n = 406
Mild 
n = 240
Moderate 
n = 106
Severe 
n = 60 P value
Male n (%) 217 (53.5) 123 (51.3) 59 (55.7) 35 (58.3) 0.535
Age (years) 51.5 ±19.0 52.6 ±19.7 47.9 ±18.3 53.5±16.0 0.068
Pain n (%) 264 (65.0) 161 (67.1) 72 (67.9) 31(51.7) 0.062
Nausea n (%) 112 (27.6) 51 (21.3) 38 (35.9) 23 (38.3) 0.002
Oedema n (%) 142 (35.0) 36 (31.3) 16 (28.6) 12 (41.4) 0.283
Seizures n (%)  38 (9.4) 20 (8.3) 9 (8.4) 9 (15.0) 0.267
GCS ≤ 13 n (%)  76 (18.7) 36 (15.0) 19 (17.9) 21 (35.0) 0.002
Systolic BP (mmHg) 134.5 ± 36.8 132.6 ±3 4.6 132.0 ± 36.6 146.4 ± 43.7 0.024
Diastolic BP (mmHg) 82.3 ± 22.3 81.6 ± 21.1 81.1 ± 24.3 87.3 ± 23.3 0.170
Serum sodium (mmol/L) 128.7 ± 6.5 132.3 ± 1.4 127.3 ± 1.6 116.4 ± 7.9 < 0.001
Random blood glucose (mmol/L) 8.7 (6.9–11.3) 8.8 (7.1–11.6) 8.2 (6.8–11.0) 9.1 (7.2–10.8) 0.528
Haemoglobin (g/dL) 10.2 ± 3.1 10.5 ± 3.1 9.5 ± 2.8 9.9 ± 3.4 0.013
Serum albumin (g/L) 31.6 ± 16.5 31.4 ± 9.1 28.6 ± 7.8 29.4 ± 12.0 0.026
Serum urea (mmol/L) 6.9 (3.9–15.6) 5.5 (3.4–11.1) 7.7 (4.9–24.5) 11.5 (5.5–29.0) 0.0001
Serum creatinine (μmol/L) 59 (61–232.5) 86 (60–153) 96 (61–349) 148 (75.5–486.5) 0.002
In-hospital mortality n (%) 129 (31.8) 50 (20.8) 48 (45.3) 31 (51.7) < 0.001
Length of hospital stay (days) 7 (4–10) 7 (4–10.5) 6.5 (3–10) 6.5 (3–11) 0.639
Continuous variables reported as mean ± standard deviation or median (interquartile range); GCS, Glasgow Coma Scale.
table 2.  Determinants of mortality among patients with 
hyponatraemia.
Died  
(n = 129)
Survived (n 
= 277) P value
Male n (%) 71 (33) 146 (67) 0.661
Age (years) 51.2 ± 19.7 51.7 ± 18.7 0.807
Pain n (%) 75 (28.4) 189 (71.6) 0.047
Nausea n (%) 43 (38.4) 69 (61.6) 0.077
Dehydration n (%) 28 (29.8) 66 (70.2) 0.637
Oedema n (%) 38 (26.8) 104 (73.2) 0.112
Seizures n (%) 17 (44.7) 21 (55.3) 0.071
GCS ≤ 13 51 (67.1) 25 (32.9) < 0.001
Systolic BP (mmHg 134.8 ± 36.1 134.3 ± 37.2 0.890
Diastolic BP (mmHg) 82.3 ± 22.3 82.4 ± 22.6 0.890
Serum sodium 
(mmol/L)
126.0 ± 8.5 129.9 ± 4.8 < 0.001
Critical 
hyponatraemia n (%)
19 (70.4) 8 (29.6) < 0.001
Random blood 
glucose
8.6 
(7.1–11.1)
8.7 
(6.8–11.5)
0.981
Haemoglobin (g/dL) 9.7 ± 3.1 10.4 ± 3.1 0.027
Serum albumin (g/L) 28.4 ± 10.2 31.3 ± 8.7 0.006
Serum urea 
(mmol/L)
8.3 
(4.8–20.7)
6.2 
(3.5–12.7)
0.005
Serum creatinine 
(μmol/L)
103 
(71–342)
89 (59–176) 0.026
Length of hospital 
stay (days)
4 (2–9) 7 (4–11) < 0.001
Continuous variables reported as mean ± standard deviation or median 
(interquartile range); GCS, Glasgow Coma Scale.
table 3.  logistic regression for variables associated with 
mortality in patients with hyponatraemia.
Odds ratio (95% 
confidence interval) P value
Serum albumin 
concentration
0.97 (0.95–1.00) 0.124
Haemoglobin 0.93 (0.85–1.02) 0.114
Critical hyponatraemia 1.13 (0.25–5.16) 0.867
Serum sodium 
concentration
0.91 (0.87–0.98) 0.009
GCS ≤ 13 7.7 (4.09–14.50) < 0.001
Pain 0.94 (0.55–1.61) 0.829
Critical hyponatraemia refers to serum sodium less than 120 mmol/L; GCS, 
Glasgow Coma Scale.
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ADH release and water retention [2,4].  Infections identified 
in our cohort included pneumonia, encephalitis, urinary 
tract infection, sepsis, and HIV with its related infections. 
Hyponatremia occurs in around 30% of HIV-infected 
patients [16]. Infections are more common in low- and 
lower-middle-income countries and this may account for 
the prominence of infections as a cause of hyponatraemia 
in our cohort. 
Hypervolaemic conditions, such as chronic liver disease 
(CLD), were identified as a significant cause of hypo-
natraemia in our cohort. CLD causes hyponatraemia in 
30% of cases. The pathophysiology includes renal hypo-
perfusion, secondary hyperaldosteronism, ADH release 
and hypoalbuminemia [17].  Hyponatraemia is associated 
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Figure 1.  Causes of hyponatraemia and associated mortality in medical admissions.
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with a poor prognosis in patients with CLD [18] or other 
oedematous conditions such as heart failure [19].  
Heart failure accounted for 8.1% of patients with hypo-
natraemia in our cohort, which is less than reported in 
many other studies [20]. The mechanism is multifactorial 
but mainly due to arterial under-filling, which leads to 
neurohormonal stimulation. Medications for heart failure, 
such as thiazide diuretics, are also known causes of hypo-
natraemia [20]. Mild hyponatraemia, even without severe 
cardiac dysfunction, is associated with increased morbidity 
and mortality [21].
Diabetes mellitus was associated with 17% of the cases in 
our cohort. Hyperglycaemia-induced hyponatraemia is well 
described in the literature [22]. The high serum tonicity 
leads to movement of water from the intracellular to 
extracellular fluid compartments and hence results in a 
decrease in serum sodium concentration [23]. Osmotic 
diuresis also leads to hypovolaemia, which increases ADH 
secretion. Moreover, polydipsia contributes to dilutional 
hyponatraemia [24].
CKD is another cause of hypervolaemic hyponatraemia, 
with a prevalence of 6% in non-dialysis CKD patients [25]. 
CKD accounted for 6% of our cases. Chronic kidney disease 
is common in hospital admissions in Ghana and patients 
often present late, with advanced disease [26]. Hypo-
natraemia in CKD patients is associated with increased 
mortality [27].
Mortality occurred in over a third of cases of hypona-
traemia in our study. This was higher than in most studies, 
which report prevalences of 15–27% [7]. Mortality was 
highest among patients with malignancies, similar to other 
studies [28]. Mortality increased significantly with severity 
of hyponatraemia; this has also been reported in other 
studies [14,29]. Serum sodium predicts mortality as 
shown in most studies [7,14,27]. Mortality was significantly 
higher among those with impaired consciousness. This may 
be due to their underlying conditions and not necessarily 
the hyponatraemia [9,23]. Many medical conditions have 
hyponatraemia as a poor prognostic factor for the under-
lying condition [10,14,20].
In our study, those who died with hyponatraemia had 
signif icantly higher median serum urea and creatinine 
values. Renal impairment worsens the prognosis of most 
medical conditions [30]. 
cONcLUsIONs
Hyponatraemia is common in medical admissions in Ghana, 
and is mostly associated with infections, chronic liver 
disease, chronic kidney disease and chronic heart failure. 
There is high in-hospital mortality and this is associated 
with serum sodium concentration and an impaired level of 
consciousness.
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